Notes on drug interactions

Scrambler Therapy® is a new electro-analgesia methodology specifically studied for neuropathic and oncologic pain and, in general, for pain non-responsive to other types of drugs and forms of electro-analgesia such as TENS and implanted stimulators.

Scrambler Therapy® is a stand-alone medical electro-analgesia device and does not require combinations with other analgesic therapies.

The usage of anticonvulsants for analgesic purposes generally calls for more treatments, needed for the weaning. The first five treatments with anticonvulsants can provide unstable results that return to normal with the continuation of the treatment cycle. The protocol for patients who use anticonvulsants typically includes 10 treatments plus those required for weaning. The frequency of treatment remains unchanged. It is also possible to continue the anticonvulsants analgesic therapy; however, in this case results are not as good or are insufficient, and relapse is quicker.

From study-phase data, the combination with ketamine is incompatible since it seems to block the analgesic efficacy of the treatment. The normal analgesic effect of the treatment after the patient stops taking ketamine is still unknown. Similar suspicions also exist for muscle relaxants, which, in combination with this therapy, could also cause minor side effects.

Quick support on research and clinical best practice